These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions. Jarrahi A; Braun M; Ahluwalia M; Gupta RV; Wilson M; Munie S; Ahluwalia P; Vender JR; Vale FL; Dhandapani KM; Vaibhav K Biomedicines; 2020 Sep; 8(10):. PubMed ID: 33003373 [TBL] [Abstract][Full Text] [Related]
5. Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury. Willing AE; Das M; Howell M; Mohapatra SS; Mohapatra S CNS Neurosci Ther; 2020 Jun; 26(6):616-627. PubMed ID: 32157822 [TBL] [Abstract][Full Text] [Related]
6. Resilience to Injury: A New Approach to Neuroprotection? Singhal NS; Sun CH; Lee EM; Ma DK Neurotherapeutics; 2020 Apr; 17(2):457-474. PubMed ID: 31997268 [TBL] [Abstract][Full Text] [Related]
7. Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans. Willyerd FA; Empey PE; Philbrick A; Ikonomovic MD; Puccio AM; Kochanek PM; Okonkwo DO; Clark RS J Neurotrauma; 2016 Jan; 33(2):226-31. PubMed ID: 25891836 [TBL] [Abstract][Full Text] [Related]
8. Emerging therapies in traumatic brain injury. Kochanek PM; Jackson TC; Ferguson NM; Carlson SW; Simon DW; Brockman EC; Ji J; Bayır H; Poloyac SM; Wagner AK; Kline AE; Empey PE; Clark RS; Jackson EK; Dixon CE Semin Neurol; 2015 Feb; 35(1):83-100. PubMed ID: 25714870 [TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation in brain or spinal cord mitochondria after injury. Hall ED; Wang JA; Bosken JM; Singh IN J Bioenerg Biomembr; 2016 Apr; 48(2):169-74. PubMed ID: 25595872 [TBL] [Abstract][Full Text] [Related]
10. Hydrophilic carbon clusters as therapeutic, high-capacity antioxidants. Samuel EL; Duong MT; Bitner BR; Marcano DC; Tour JM; Kent TA Trends Biotechnol; 2014 Oct; 32(10):501-5. PubMed ID: 25175886 [TBL] [Abstract][Full Text] [Related]
11. Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury. Mendes Arent A; de Souza LF; Walz R; Dafre AL Biomed Res Int; 2014; 2014():723060. PubMed ID: 24689052 [TBL] [Abstract][Full Text] [Related]
13. Antioxidant therapies in traumatic brain and spinal cord injury. Bains M; Hall ED Biochim Biophys Acta; 2012 May; 1822(5):675-84. PubMed ID: 22080976 [TBL] [Abstract][Full Text] [Related]
14. Antioxidant therapies for traumatic brain injury. Hall ED; Vaishnav RA; Mustafa AG Neurotherapeutics; 2010 Jan; 7(1):51-61. PubMed ID: 20129497 [TBL] [Abstract][Full Text] [Related]
15. Role of animal studies in the design of clinical trials. Hall ED; Traystman RJ Front Neurol Neurosci; 2009; 25():10-33. PubMed ID: 19478492 [No Abstract] [Full Text] [Related]
16. PEG-SOD after head injury. Muizelaar JP; Kupiec JW; Rapp LA J Neurosurg; 1995 Nov; 83(5):942. PubMed ID: 7472573 [No Abstract] [Full Text] [Related]
17. Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury. Muizelaar JP Adv Exp Med Biol; 1994; 366():389-400. PubMed ID: 7771267 [No Abstract] [Full Text] [Related]
18. Cerebral ischemia-reperfusion injury after severe head injury and its possible treatment with polyethyleneglycol-superoxide dismutase. Muizelaar JP Ann Emerg Med; 1993 Jun; 22(6):1014-21. PubMed ID: 8503521 [TBL] [Abstract][Full Text] [Related]
19. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. Muizelaar JP; Marmarou A; Young HF; Choi SC; Wolf A; Schneider RL; Kontos HA J Neurosurg; 1993 Mar; 78(3):375-82. PubMed ID: 8433137 [TBL] [Abstract][Full Text] [Related]